Zio XT ECG Monitoring System vs Rhythm360
AI Verdict
Choose Zio XT ECG Monitoring System if…
Choose Zio XT if your primary need is a highly compliant, patient-friendly solution for extended, continuous ambulatory ECG monitoring to detect arrhythmias. Its wearable, water-resistant biosensor and lack of external wires make it ideal for patients requiring up to 14 days of comfortable, uninterrupted monitoring in their daily lives.
View Zio XT ECG Monitoring System →Choose Rhythm360 if…
Choose Rhythm360 if your practice manages a diverse patient population with various cardiac devices and requires a unified platform for comprehensive data aggregation and workflow optimization. This tool excels at reducing alert fatigue through AI-driven triage, streamlining EHR integration, and automating billing processes across multiple device types.
View Rhythm360 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio XT ECG Monitoring System | Rhythm360 |
|---|---|---|
| Pricing | Contact for pricing | Flexible pricing model that scales with clinic size and platform usage. |
| Deployment | Cloud-based (AWS EC2 platform), no on-premise hardware required. | Cloud-based SaaS platform |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio XT ECG Monitoring SystemZio XT excels in patient usability with its comfortable, wire-free, and water-resistant wearable biosensor, leading to high patient compliance (up to 99%). While Rhythm360 offers strong clinician-focused usability features like alert triage and EHR integration, Zio XT's direct impact on patient comfort and ease of use for continuous monitoring gives it an edge in overall system usability from the primary user's perspective.
Clinical Value
Rhythm360Rhythm360 offers broader clinical value by unifying data from various cardiac devices and providing actionable insights for multiple conditions, including hypertension, heart failure, and rhythm management. Its predictive algorithms for heart failure management and ability to reduce alert fatigue demonstrate a more comprehensive approach to cardiac care beyond just arrhythmia detection, which is Zio XT's primary focus.
Pricing & Value
Zio XT ECG Monitoring SystemZio XT provides more transparent pricing details, with specific costs available for the UK (u00a3310 per patient) and proposed Medicare rates in the US ($229-$260.35). In contrast, Rhythm360 describes a flexible, SaaS-based model that scales with usage, but also notes 'premium pricing' as a potential con, making its value proposition less clear without direct contact.
Enterprise Readiness
Rhythm360Rhythm360 demonstrates superior enterprise readiness through its extensive bi-directional EHR integrations (Epic, Cerner, Athenahealth, etc.), vendor-neutral data aggregation from all major OEMs, and automated CPT code documentation and billing. These features are crucial for seamless integration into large healthcare systems and streamlining administrative workflows.
Innovation
Rhythm360While Zio XT features an innovative wearable biosensor with FDA-cleared AI for arrhythmia detection, Rhythm360 showcases broader innovation in its AI-powered integrated platform. Its ability to unify data from diverse devices, apply AI for multiple conditions (hypertension, heart failure, rhythm management), and perform advanced AI Data Normalization, including PDF parsing via computer vision, represents a more complex and comprehensive technological advancement.
Support & Docs
Rhythm360Rhythm360 explicitly highlights an 'Optional 24/7/365 oversight by certified cardiac technicians (CCTs)' as a key feature, indicating a robust and continuous support model. While Zio XT offers general patient and professional resources, the direct mention of round-the-clock expert oversight for Rhythm360 suggests a higher level of dedicated support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio XT ECG Monitoring System | Rhythm360 |
|---|---|---|
| Name | Zio XT ECG Monitoring System | Rhythm360 |
| Company | iRhythm Technologies | RhythmScience |
| Primary Function | Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for arrhythmia detection and diagnosis. | AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue. |
| Key Monitoring/Data Source | Wearable single-lead ECG biosensor (Zio biosensor) for continuous ambulatory cardiac monitoring for up to 14 days. | Vendor-neutral data aggregation from all major OEM cardiac devices (Medtronic, Boston Scientific, Abbott, Biotronik). |
| AI Capabilities | Proprietary, FDA-cleared deep-learned AI algorithm for ECG data analysis. | AI-driven alert triage (80% faster response times, reduces alert fatigue), AI Data Normalization (API, HL7, XML, PDF parsing via computer vision), predictive algorithms for Heart Failure Management. |
| EHR Integration | Not specified | Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity). |
Videos
Demos, reviews, and walkthroughs featuring Zio XT ECG Monitoring System and Rhythm360.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio XT ECG Monitoring System or Rhythm360
Backers
Who funded each tool's parent company.